Please login to the form below

Not currently logged in
Email:
Password:

New UK managing director for Lilly

Dr Jean-Michel Cossery takes over from Ramona Sequeira

Lilly Dr Jean-Michel CosseryLilly has appointed Dr Jean-Michel Cosséry as its new UK managing director and vice president for its Northern Europe hub.

He takes over from Ramona Sequeira, who spent three years in the role and now moves to Indianapolis, USA to take up a new position within the pharma company's corporate centre.

Dr Cosséry said: “I am delighted at this opportunity to join Lilly in this role because I share the company's commitment to the patient and its dedication to innovation and research.

“The next few years will be a challenging time for the UK pharmaceutical industry, but I have every confidence in Lilly's ability to deliver on the promise of its pipeline.”

Dr Cosséry joined Lilly in October from GE Healthcare, where he spent eight years as vice president and chief marketing officer.

Dr Cosséry began his career as a neuroscience researcher and prior to joining GH he held senior pharma management positions at companies such as Novartis, Serono and Laboratoire Fournier.

Commenting on Dr Cosséry's appointment Andrew Hotchkiss, Lilly's president of the Australia, Canada and Europe region, said: “I am delighted to welcome Jean-Michel to Lilly, and believe his experience will be extremely beneficial as we prepare to launch our new products. We look forward to the leadership he will provide to our organisation and the patients we serve.”

12th December 2012

From: Research, Sales, Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics